Buy 10x Genomics with a 1-year target of $12.7, projecting 18% growth. Read here for more on TXG stock's biopharma potential ...

10x Genomics (NASDAQ:TXG – Get Free Report) had its price target reduced by investment analysts at Citigroup from $20.00 to $15.00 in a note issued to investors on Tuesday,Benzinga reports.

*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title ...

Popcorn is one of my all-time favorite snacks, especially now that I have to eat gluten-free. It's a quick way to fill me up without having to worry about what's in it. Whether it's buttery movie ...

Approximatively 10,000 cells from each lung sample were loaded in a Chromium Controller or Chromium iX instrument (10x Genomics, Pleasanton, CA) and encapsuled with unique barcoded primers using the ...

10x Genomics has a fifty-two week low of $9.77 and a fifty-two week high of $45.60. The firm’s 50 day moving average price is $13.90 and its 200 day moving average price is $16.67. Get 10x ...

PLEASANTON, Calif., March 3, 2025 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG), a leader in single-cell and spatial biology, today provided an update on its patent litigation with Parse Biosciences.

Investing.com -- Tesla (NASDAQ:TSLA) CEO Elon Musk said over the weekend that profits at the automaker could grow 1000% over the next 5 years if the company can execute. In response to a comment ...

LONDON--(BUSINESS WIRE)-- Cykel AI PLC (LSE: CYK) today announced an advancement in its artificial intelligence (AI) digital worker as Lucy, an AI-powered recruitment agent, demonstrated advanced ...

1 School of Computer and Information Engineering, Luoyang Institute of Science and Technology, Luoyang, China 2 State Key Laboratory of Bioelectronics; School of Biological Science & Medical ...